Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 2011. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, rather than a comprehensive financial statement.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is limited to reporting specific share transactions and does not contain financial performance data.
Material Changes
The filing details a specific transaction involving a Person Discharging Managerial Responsibility:
- Individual: Mrs. V A Whyte
- Transaction: Transfer of 799 Ordinary shares in GlaxoSmithKline plc to Mr. I W Whyte.
- Date: May 5, 2011
- Notification Date: May 5, 2011
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document strictly adheres to the notification requirements under Disclosure Rule 3.1.4R(1)(a) and (c).
Investor Verification Points
- Verify the identity of the connected person (Mr. I W Whyte) receiving the shares.
- Confirm the total shareholding of Mrs. V A Whyte post-transaction to assess ongoing exposure.
- Note that this filing does not reflect operational or financial performance for the period.